Statement from Health Canada concerning access to cannabis for medical purposes
SOURCE Health Canada
For further information: Contacts : Media Relations, Health Canada, (613) 957-2983 Public Inquiries, (613) 957-2991, 1-866 225-0709
Government of Canada moves forward on Marijuana Legalization and Regulation
CanadaTask force and public consultation to inform creation of a new system that will protect and inform Canadians
"We have confidence that the individuals who make up the Task Force have the expertise, knowledge and credibility necessary to provide us with thoughtful advice on the design of a system of strict marijuana production, distribution, and regulated sales."
Minister of Justice and Attorney General of Canada"Our Government is moving forward with an approach to marijuana that is both comprehensive and evidence-based. We are committed to moving ahead in a responsible way, acknowledging and addressing the health risks associated with recreational use of marijuana, especially the health risks to young Canadians."
Minister of Health"Our Government's efforts to legalize and regulate marijuana will help keep it out of the hands of children, prevent drug-impaired driving, and stop criminals from profiting from it. These public safety imperatives are at the core of our plan. The Task Force, which includes experts in the fields of law enforcement and justice, will ensure this process is accomplished in a safe and orderly manner."
Minister of Public Safety and Emergency Preparedness"I am proud to be part of this historic, open and transparent engagement process, and I am confident that the resulting legislation will be robust and well informed by the input of experts in many fields, as well as individual Canadians."
Parliamentary Secretary to the Minister of Justice and Attorney General of Canada
Health Minister confirms Canada's way forward on marijuana for medical purposes
OTTAWA, March 24, 2016 /CNW/ - Today, the Honourable Jane Philpott, Minister of Health, issued the following statement regarding the matter of Allard v. Canada:
Following a careful review of the Federal Court's decision in the matter of Allard v. Canada, the Government of Canada has decided not to appeal the decision. In the coming months, the Marihuana for Medical Purposes Regulations (MMPR) will be amended to give effect to the Court's judgement. The Government's intention is to have completed the amendment process by August 24, 2016, which is the timeframe set by the judgement
In the meantime, I would like to remind authorized medical marijuana users that the MMPR remain in full effect. Unless one is covered by a Court injunction, Licensed Producers are the only legal way to obtain marijuana for medical purposes.
At the same time, our Government will be moving forward with the legalization, strict regulation and restriction of access to marijuana. In the near future, a Task Force will be established that will consult broadly with experts in public health, substance abuse and law enforcement in order to examine and report on all of the issues related to legalization.
The Honourable Jane Philpott, P.C., M.P.
Minister of Health
SOURCE Health Canada
For further information: Andrew MacKendrick, Office of Jane Philpott, Minister of Health, (613) 957-0200; Media Relations: Health Canada, (613) 957-2983
Ban on medical marijuana patients growing own pot struck down by Federal CourtShutterstock/Ketta
By Mike Laanela on February 24, 2016
A Federal Court judge has struck down federal regulations restricting the rights of medical marijuana patients to grow their own cannabis and given the Liberal government six months to come up with new rules.
Judge Michael Phelan ruled Wednesday in Vancouver that the Marijuana for Medical Purposes Regulations were an infringement on charter rights and declared they have no force and effect.
But the judge also suspended his declaration for six months to give the federal government time to come up with new rules.
Tweed Connects with Snoop Dogg!
Pot.Ca comment : Big wave of good energy. The present and future are bright.
Marijuana regulation is coming to Canada — here are five things to know
Canada may become the second country to implement legalization of marijuana nationally. Nazlee Maghsoudi, with the International Centre for Science in Drug Policy, explains the thinking behind such legislation.
If you paid any attention during the run up to the federal election, you know about Prime Minister Justin Trudeau’s promise to regulate recreational cannabis use in Canada. From the inclusion of cannabis policy reform in the speech from the throne to the mandate letter to the Minister of Justice, the Liberals have shown that they see this issue as a major part of their platform and they are committed to following through. And with a majority Liberal government in place, Canada appears all but set to become the second country in the world after Uruguay to develop a national regulatory framework for cannabis. Nazlee Maghsoudi, with the International Centre for Science in Drug Policy, explains the thinking behind such legislation.
Here are the 5 Questions Nazlee Maghsoudi tackles:
Scientists demand a new approach to evaluating illicit drug policy
TORONTO, Jan. 21, 2016 /PRNewswire-USNewswire/ -- Scientific experts from around the world are calling on governments to better align illicit drug policy goals with community concerns. According to an open letter released by the International Centre for Science in Drug Policy (ICSDP), while governments measure illicit drug policies primarily based on their capacity to reduce the availability of illicit drugs, this ignores the 'real world' impact of drug policies on the health, security, development, and human rights of affected communities. This call comes as the international community focuses unprecedented attention towards the world drug problem.
In advance of the United Nations General Assembly Special Session on Drugs (UNGASS) – the largest international meeting on drug policy since 1998 – leading researchers are asking national governments and UN agencies to commit to revising the indicators currently used to evaluate drug control policies. Scientists held a panel to release the open letter at the United Nations Headquarters in New York City today, where the UNGASS will be held in April this year.
"To date, the impact of drug policies has traditionally been measured using a very narrow set of indicators totally detached from community concerns about health, safety, human rights and development," said Dr. Dan Werb, Director of the ICSDP. "The scientific evidence suggests that conventional drug policies have little to no impact on patterns of illicit drug use. What's equally important, though, is that these conventional indicators – like the amount of drugs seized or the price and purity of illicit drugs – totally fail to capture the most important ways in which drugs and drug policies affect communities."
The open letter, signed by leading drug policy experts – including Dr. Michel Kazatchkine, Member of the Global Commission on Drug Policy, and Dr. Julio Montaner, Director of the British Columbia Centre for Excellence in HIV/AIDS – outlines extensive scientific evidence that the indicators used to evaluate drug policy ignore some of the most important community impacts. In response, the open letter includes a preliminary set of suggested indicators that allow for governments to better assess the health, security, development and human rights impacts of their drug policies.
Dr. David Nutt, Professor of Neuropsychopharmacology at Imperial College London, explained, "Governments have yet to systematically measure and evaluate their policies based on health and security outcomes experienced by communities. These outcomes include the numbers of fatal overdose, blood-borne disease transmission rates, or traffic accidents – all of which have a far more meaningful impact on communities than measuring the level of drug use in the general population, or the amount of drugs that have been seized annually. While these may be important statistics, they tell us very little about how drugs are impacting communities."
Seventeen Years After Setting the Wrong Goal, the UN Aims to Get Drug Policy Right
on Dec 17, 2015
What do drug experts in Africa, Latin America, Asia, and the United States have in common? They all recognize that the war on drugs has failed, and that it’s time for a change.
It’s been 17 years since world leaders assembled at the 1998 special session of the United Nations to discuss the global drug problem. The slogan of that meeting was, “A Drug-Free World: We Can Do It.” But they couldn’t do it. The effort to eliminate all drug production and impose a zero-tolerance approach to drug use didn’t work. In fact, these efforts have done more harm than good the world over.
Significant changes in the global drug policy landscape are shaping up in the UNGASS 2016 preparations, in the direction of more humane and proportional responses based on health, human rights and development principles. But few countries are willing to openly acknowledge the existence of structural deficiencies with regard to UN system-wide coherence, the institutional architecture and the legal treaty framework. In spite of more and more cracks in the Vienna consensus and treaty breaches in the area of cannabis policies, questioning the basic principles of the international drug control system is still largely a political taboo.
Download the memo (PDF)